Wear it pink this October Wear pink. Raise money. Help make life-changing breast cancer research and support happen.
Book a Public Health Talk Raise awareness of breast cancer in your local community or network by booking a free online or in-person talk.
Home About us Media Breast Cancer Now media statements 210 results Breast Cancer Now responds to the HSJ and BBC Newsnight's joint special investigation about long cancer waits 11 Aug 2022 1 min read We respond to research about physical activity and breast cancer risk 07 Sept 2022 1 min read We respond to research about breast cancer surgery margins 22 Sept 2022 1 min read We welcome approval of palbociclib with fulvestrant for routine use on the NHS 23 Sept 2022 1 min read Fantastic outcome for certain patients with incurable secondary triple negative breast cancer as pembrolizumab (Keytruda) in combination with chemo (paclitaxel or nab-paclitaxel) is approved for use on the NHS in Scotland 10 Oct 2022 1 min read Breast Cancer Now responds to latest NHSE Cancer Wait Times data, calling for the FDS to be raised to 95% 13 Oct 2022 1 min read Breast Cancer Now responds to NICE provisional decision not to recommend pembrolizumab (Keytruda) in combination with chemotherapy (paclitaxel or nab-paclitaxel) 08 Mar 2022 3 min read We respond to NHS England breast cancer waiting times: January 2022 10 Mar 2022 1 min read We respond to NHS England's proposed new standards 09 Mar 2022 1 min read We respond to new data from major trial OlympiA shows adjuvant olaparib improved survival in patients 16 Mar 2022 1 min read We respond to research about artificial sweeteners and breast cancer risk 24 Mar 2022 1 min read We respond to NICE provisional decision not to recommend alpelisib with fulvestrant for routine use on the NHS 01 Apr 2022 1 min read Previous 1 ... 11 ... 18 Next
Breast Cancer Now responds to the HSJ and BBC Newsnight's joint special investigation about long cancer waits 11 Aug 2022 1 min read
We welcome approval of palbociclib with fulvestrant for routine use on the NHS 23 Sept 2022 1 min read
Fantastic outcome for certain patients with incurable secondary triple negative breast cancer as pembrolizumab (Keytruda) in combination with chemo (paclitaxel or nab-paclitaxel) is approved for use on the NHS in Scotland 10 Oct 2022 1 min read
Breast Cancer Now responds to latest NHSE Cancer Wait Times data, calling for the FDS to be raised to 95% 13 Oct 2022 1 min read
Breast Cancer Now responds to NICE provisional decision not to recommend pembrolizumab (Keytruda) in combination with chemotherapy (paclitaxel or nab-paclitaxel) 08 Mar 2022 3 min read
We respond to new data from major trial OlympiA shows adjuvant olaparib improved survival in patients 16 Mar 2022 1 min read
We respond to NICE provisional decision not to recommend alpelisib with fulvestrant for routine use on the NHS 01 Apr 2022 1 min read
